{"disease":{"id":"type-1-diabetic-nephropathy","name":"type 1 diabetic nephropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07332819","title":"Resveratol in Diabetic Nephropathy","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT06115460","title":"The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT03840343","title":"Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}